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ANG II and ANG-converting enzyme (ACE) inhibitors contribute to the development and regression of cardiac hypertrophy, respectively, both in vitro and in vivo (22, 27, 33, 44) . Release of ANG II, for example, mediates stretch-induced hypertrophy of cardiac myocytes in vitro (32) . ACE inhibitors improve diastolic function and alter the abundance of several transcripts implicated in calcium cycling, including those of the SR Ca 2ϩ -ATPase (9, 43) . We previously demonstrated, however, that the amount of SERCA2 mRNA is not an accurate predictor of SR Ca 2ϩ -ATPase protein abundance (6, 31) and that administration of ramipril alone to normal rats could modify cardiac SERCA2 and PLB mRNA expression without affecting the abundance of either protein (6) . In guinea pigs, high-dose ACE inhibition prevents a decrease in SR calcium cycling protein abundance in the pressure-overloaded heart (38) . In compensated cardiac hypertrophy, we previously showed that subantihypertensive doses of ramipril similarly increase SR Ca 2ϩ -ATPase protein abundance and improve uptake in crude cardiac homogenates (6) . It remains unclear how low-dose ACE inhibition in established cardiac hypertrophy actually improves myocyte relaxation (6) . We therefore performed the present study to test whether rats with established cardiac hypertrophy and treated with ramipril show improved relaxation in isolated myocytes. Specifically we hypothesized that subantihypertensive doses of ramipril would improve myocyte relaxation through 1) enhanced SR Ca We demonstrate that in compensated cardiac hypertrophy the slowing of myocyte relaxation after rapid cooling is in fact reversible with ramipril treatment. Specifically, ramipril treatment improves myocyte time to peak (TTP) contraction and normalizes myocyte relaxation and Ca 2ϩ handling. The improvement in relaxation is mediated primarily through improved SR uptake by the SR Ca 2ϩ -ATPase and through enhanced Ca 2ϩ efflux from the cell independent of measurable changes in Na ϩ /Ca 2ϩ exchanger mRNA and protein expression.
METHODS

Model of Cardiac Hypertrophy
Male Sprague-Dawley rats weighing 225-250 g were anesthetized with ketamine (60 mg/kg body wt) and medetomidine (0.25 mg/kg), and the descending aorta was constricted as previously described (7, 6) . Five weeks after surgery rats received a daily oral dose (50 g ⅐ kg Ϫ1 ⅐ day Ϫ1 ) of ramipril or vehicle (polyethylene glycol) for 4 wk. Four experimental groups were studied: sham operated (controls) ϩ vehicle, sham operated (controls) ϩ ramipril, hypertrophy ϩ vehicle, and hypertrophy ϩ ramipril. Nine weeks postoperatively the rats were killed by cervical dislocation, and the hearts were removed and washed in ice-cold normal Tyrode solution consisting of the following (in mM): 140 NaCl, 6 KCl, 1 MgCl 2 , 10 glucose, and 10 HEPES containing 2 CaCl 2 at pH 7.4.
Study of Cardiac Myocytes
Myocyte cell isolation. Myocytes were isolated by enzymatic dissociation with retrograde perfusion of the whole heart as previously described (28, 39) except that the lowCa 2ϩ medium was composed of the following (in mM): 120 NaCl, 5.4 KCl, 5 MgSO 4 , 5 pyruvate, 20 glucose, 20 taurine, 10 HEPES, and 5 nitroloacetic acid (NTA) and 40 M free Ca 2ϩ . After 5 min in low-Ca 2ϩ solution, the heart was perfused with 0.3 mg/ml collagenase (Worthington) and 0.6 mg/ml hyaluronidase (Sigma). Enzymes were dissolved in the low-Ca 2ϩ medium without NTA and with a free Ca 2ϩ concentration ([Ca 2ϩ ]) of 200 M. The left ventricle was chopped and shaken in fresh collagenase mixture for two periods of 5 min each. After filtering was completed, the cells were placed in DMEM solution buffered with 25 mM HEPES (GIBCO-BRL) at room temperature. In this medium the cells remained viable and could be used over a period of 3-4 h.
Cell shortening and Ca 2ϩ measurements. Cell shortening was measured using a video-based edge-detection system described by Steadman and colleagues (36) . Fluorescence measurements indicating changes in intracellular [Ca 2ϩ ] ([Ca 2ϩ ] i ) were made on the same cells employed in the cellshortening measurements using the dual-emission fluorescent dye indo 1 as previously described (28, 39) . Cells were placed in a Plexiglas superfusion chamber (60-l vol) situated on the stage of an epifluorescence microscope. Cell adhesion to the floor of the chamber was improved by a thin coating of mouse laminin (GIBCO-BRL). Cells were field stimulated at 0.5 Hz via a pair of platinum electrodes placed on either side of the experimental chamber and continuously superfused at a rate of 2-3 ml/min with a Tyrode solution containing (in mM) 140 NaCl, 6 KCl, 1 MgCl 2 , 2 CaCl 2 , 10 glucose, and 10 HEPES, with pH 7.4 Ϯ 0.01. All experiments were carried out at room temperature (22°C) except during the cooling periods that brought about rapid cooling contractures (RCCs). When Na ϩ -free/Ca 2ϩ -free solution was used, Na ϩ was substituted by 140 mM Li ϩ , Ca 2ϩ was omitted, and 0.75 mM EGTA was added, at pH 7.4 Ϯ 0.01. When caffeine was used, it was added to normal Tyrode for a final concentration of 10 mM.
RCCs. The methods used to invoke RCCs have been well described (3, 4, 8, 21, 28, 40) . Briefly, RCCs were generated 2 s after cessation of field stimulation. The temperature of the solution superfusing the cells was changed from 22°C to 1°C in Ͻ1 s (39) . This produced an increase in cytoplasmic [Ca 2ϩ ] and a contracture, which have been described in detail (4). Rapid switching of the solutions was achieved by a system of solenoid valves placed near the cell chamber. Solutions were kept cold by placing them in a water-ethylene glycol mixture (4:1 ratio) kept at Ϫ3.5°C in a circulating water bath. The tubing carrying the solutions was also jacketed with cold water/ethylene glycol solution. During cooling, solutions flowed through the cell chamber at a rate of 12-15 ml/min. After the cooling contracture reached a plateau, the cell was rewarmed by switching the solutions back to room temperature allowing the cell to relax.
Data acquisition and statistics. Signals from the video edge-detection system and the fluorescence apparatus were recorded simultaneously on tape and computer using a digitization rate of 0.1 kHz and Axotape 2.0 software (Axon Instruments, Foster City, CA). For the measurement of the myocyte twitch and fluorescence transient parameters, four consecutive twitches and transients were signal averaged. TTP was measured between the point before the initial increase of the signal and the peak of the signal. Time to 50% relaxation or decline (R 50 ) was measured between the peak of the signal to the point on the declining phase corresponding to half of the total size of the twitch or transient. Time to 90% relaxation or decline (R 90 ) was measured between the peak of the signal to the point where the declining phase had recovered by 90% of the total size of the twitch or transient.
Measurement of myocyte cell size. Video hard copies of a representative population (n Ϸ 30) of myocytes were taken from each of the heart preparations using a Video Graphic printer (UP 701, Sony, Japan). Two-dimensional surface areas of the cells were obtained from these hard copies using a digitizing tablet and its associated software (VIDS III, Analytical Measuring Systems, Cambridge). Cell width and cell length were measured from each myocyte and averaged for each heart.
RNA and Protein
Because of potential RNA and protein degradation during the preparation of adult rat cardiac myocytes, a separate set of experimental animals was used for RNA and protein sample preparations. Experimental animals were treated identically to those used for preparing isolated cells. Left ventricles from each animal were isolated and divided into two parts for preparation of both RNA and protein.
RNA isolation. Total RNA was prepared from freshly isolated rat left ventricles as previously described (6) . RNA was prepared from eight animals from each experimental group and stored as an ethanol precipitate at Ϫ20°C.
RNase protection assays. Na ϩ /Ca 2ϩ exchanger (NCX1) mRNA was measured by RNase protection assay (RPA) as previously described (19) . cRNA probes were prepared using T 7 RNA polymerase in the presence of 1.85 MBq 32 UTP and 1.0 g of linearized plasmid [BamHI-digested plasmid pRCNaCa10 and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) plasmid (Ambion)]. Full-length probes were 699 and 383 bp and had specific activities of 3.2 ϫ 10 8 and 1.8 ϫ 10 8 cpm/mg, respectively. RPAs were performed on 5 g of total RNA using 5 ϫ 10 4 counts per minute (cpm) Na ϩ /Ca 2ϩ exchanger probe and 5 ϫ 10 4 cpm GAPDH probe per reaction. After separation on a 6% denaturing polyacrylamide gel, dried gels were exposed to X-ray film for between 2 h (GAPDH) and 90 h (Na ϩ /Ca 2ϩ exchanger) and quantitated using a phosphoimager. Results were expressed as the densitometric ratio of Na ϩ /Ca 2ϩ exchanger to GAPDH. Protein analysis by Western blotting. Protein preparation and Western blots were performed as previously described (6, 19) . Frozen tissue (50-150 mg) was homogenized in seven volumes of lysis buffer [in mM: 20 HEPES, 4 EGTA, and 1 dithiothreitol (pH 7.5) containing 1 phenylmethylsulfonyl fluoride and 0.3 leupeptin], and 100 g of total protein in one volume of loading buffer were separated on 4% SDS-7.5% polyacrylamide gels and transferred to nitrocellulose membranes (Hybond-C super, Amersham). Protein was detected using a 1:1,000 dilution of a polyclonal Na ϩ /Ca 2ϩ primary antibody (Swant) and a 1:15,000 dilution of a horseradishperoxidase-coupled secondary antibody (goat anti-rabbit, Dako). Enhanced chemiluminescence films were scanned at 176 m of resolution using a Molecular Dynamics laser densitometer and analyzed by the One dimensional software package (12) . To ensure equal protein loading, membranes were reprobed with a monoclonal antibody to myosin heavy chain (MHC, Novocastra Laboratories) and subsequently stained with 0.15% amido black as previously described (6) .
Statistics
Data are expressed as means Ϯ SE. Results collected for both cell contraction and indo 1 fluorescence were from Ն8 cells in each heart. The measurements from these Ն8 cells were averaged to provide a mean value for that heart; n ϭ number of hearts, and a minimum of five hearts was studied from each group. The data groups were compared using one-way ANOVA followed by a Tukey-Kramer multiple comparisons test. Significance was taken at P Ͻ 0.05.
RESULTS
Cardiac and myocyte hypertrophy. Nine weeks after aortic constriction, heart wt increased by 36% (P Ͻ 0.001). At this time, body wt and tibial length were unchanged between each of the experimental groups (P Ͼ 0.05). Heart weight-to-tibial length ratio increased by 43% (P Ͻ 0.001) after cardiac hypertrophy but was not significantly reduced after ramipril treatment. Aortic constriction also led to a significant increase in myocyte cell length (P Ͻ 0.01) and width (P Ͻ 0.05). Four weeks of low-dose ramipril treatment did not significantly decrease cell size or reduce cardiac mass (P Ͼ 0.05).
Myocyte contractile properties. With myocyte hypertrophy, the TTP of contraction slowed and the time of relaxation lengthened (Fig. 1) . After ramipril treatment these twitch characteristics improved; however, slowing of both contraction and relaxation in hypertrophied myocytes was not accompanied by similar changes in intracellular Ca 2ϩ transients. Specifically, the TTP of contraction slowed by 36% (control ϩ vehicle and hypertrophy ϩ vehicle; P Ͻ 0.001) after 9 wk of aortic constriction ( Fig. 2A) . Ramipril did not change the twitch characteristics of the controls; however, after 4 wk of ramipril treatment the TTP of contraction was significantly improved (P Ͻ 0.05) in the hypertrophied group. The TTP of the intracellular Ca 2ϩ transients (as measured by indo 1 fluorescence) were not significantly different between any groups, suggesting that myofilament sensitivity had been altered.
Measurement of the R 50 of the twitch (Fig. 2B ) demonstrated that in cardiac hypertrophy, myocytes had relaxation times that were 80% slower than controls on vehicle alone (P Ͻ 0.01). Ramipril treatment significantly reduced the mean relaxation time of the hypertrophy group (P Ͻ 0.05) but did not affect the relaxation times of controls. No significant changes to the declining phase of the Ca 2ϩ transients could be demonstrated, again suggesting that the hypertrophy process and ramipril treatment affected myofilament Ca 2ϩ sensitivity. Similarly, the R 90 of hypertrophied cells was 74% slower than controls (Fig. 2C) . After ramipril treatment, the relaxation times significantly improved, returning the relaxation rates back to those of controls (control ϩ ramipril vs. hypertrophy ϩ ramipril; P Ͼ 0.1). Fig. 3A . Inhibition of the exchanger has only a small effect as can be predicted from its role in relaxation in this species (2); however, the presence of caffeine removes the substantial contribution of the SR to intracellular Ca 2ϩ removal during relaxation. This results in a large increase in myocyte relaxation time (Fig. 3A) . Figure 3B shows typical relaxation profiles in normal Tyrode solution of myocytes isolated from the experimental groups. Cardiac hypertrophy results in slowing of the relaxation phase induced by rewarming after a RCC. After ramipril treatment, myocyte relaxation significantly improves.
Pooled data of experiments of this type are shown in Fig. 4 . Figure 4A shows the R 50 of myocyte cell length induced by rewarming after a RCC in normal Tyrode solution. The relaxation of hypertrophied myocytes was slowed by almost 90% compared with control myocytes. After ramipril treatment, relaxation was significantly faster (hypertrophy ϩ vehicle vs. hypertrophy ϩ ramipril; P Ͻ 0.01). Ramipril treatment did not affect the relaxation of control myocytes after a RCC. Figure  4B shows the results for the decline in indo 1 fluorescence during the rewarming phase. In cardiac hypertrophy, a 48% slowing of the decline in intracellular Ca 2ϩ was observed during relaxation (P Ͻ 0.01). Ramipril treatment improved the rate of decline of the Ca 2ϩ signal in the hypertrophy ϩ ramipril group. Ramipril did not significantly alter the rate of decline of the Ca 2ϩ signal of control myocytes. These data show that after rapid cooling and a maximal release of Ca 2ϩ from the SR, there were corresponding changes in the relaxation times of cell length and the times for decline of intracellular Ca 2ϩ : these increased in cardiac hypertrophy but were improved by ramipril treatment.
Relaxation in Na-free/Ca-free solution. Relaxation in Na ϩ -free/Ca 2ϩ -free solution permitted the examination of changes in the absence of a functional Na ϩ /Ca 2ϩ exchanger (Fig. 5) . Figure 5A shows that in Na ϩ -free/ Ca 2ϩ -free solution, cardiac hypertrophy resulted in a 63% slowing of the R 50 of cell length after RCCs. After ramipril treatment, relaxation was faster (hypertrophy ϩ vehicle vs. hypertrophy ϩ ramipril; P Ͻ 0.05). Figure 5B shows the corresponding results for indo 1 fluorescence changes under these conditions. In cardiac hypertrophy a 60% slowing in the decline of fluorescence was observed during relaxation. Fluorescence declined more rapidly with ramipril treatment (hypertrophy ϩ vehicle vs. hypertrophy ϩ ramipril; P Ͻ 0.05). Ramipril did not alter the R 50 of cell length or the R 50 of the decline in fluorescence of control myocytes. These experiments suggest that SR Ca 2ϩ uptake in the intact cardiac myocyte is reduced in cardiac hypertrophy, but uptake significantly improves after ramipril -release channels is greatly increased so that the SR is no longer able to retain Ca 2ϩ . Relaxation in caffeine is then mainly a function of the Na ϩ / Ca 2ϩ exchanger. To test any potential role of the exchanger, experiments were performed in the presence of caffeine. Figure 6 shows pooled data of the R 50 myocyte relaxation and the decline in fluorescence in caffeine during rewarming after rapid cooling. No changes in relaxation rate of cell length were observed in any groups when the relaxations were carried out in the presence of 10 mM caffeine (Fig. 6A) . Caffeine is, however, well known to alter myofilament sensitivity making interpretation of the cell length changes difficult. No significant difference in the rates of indo 1 fluorescence decline between control ϩ vehicle, control ϩ ramipril, or hypertrophy ϩ vehicle could be demonstrated; however, the rate of decline of the hypertrophy ϩ ramipril group was 30% faster than the hypertrophy ϩ vehicle group; P Ͻ 0.05 (Fig. 6B) . It is unclear why the rate of decline of indo 1 fluorescence did not improve in the hypertrophy ϩ vehicle group given that we find a threefold increase in the presence of the exchanger protein (see RNA and protein measurements). The data show that ramipril treatment of the hypertrophied heart improves Ca 2ϩ extrusion from the cells, probably via the Na ϩ /Ca 2ϩ exchanger. RNA and protein measurements. To demonstrate that improved myocyte relaxation in caffeine after ramipril treatment was due to increased Na ϩ /Ca 2ϩ exchanger abundance, exchanger mRNA and protein were measured. RNA abundance was quantified using the RPA, and GAPDH mRNA abundance was used to normalize data (Fig. 7) . No significant difference in GAPDH transcript abundance could be demonstrated between the four groups. After cardiac hypertrophy, Na ϩ /Ca 2ϩ exchanger mRNA abundance almost doubled when compared with controls on vehicle (*P Ͻ 0.05). When treated with ramipril, the hypertrophy group had even higher quantities of exchanger mRNA albeit not a significant increase above the hypertrophied group. Unexpectedly, exchanger mRNA expression was most abundant in the control ϩ ramipril groups (Fig. 7B) , suggesting posttranscriptional control of exchanger protein abundance. Na ϩ /Ca 2ϩ exchanger protein abundance was therefore examined by Western blotting (Fig. 8, A and B) . Unlike the mRNA data, ramipril treatment did not increase Na ϩ /Ca 2ϩ exchanger protein in either control group, confirming a degree of posttranscriptional regulation. Cardiac hypertrophy led to a threefold increase in exchanger protein compared with controls (***P Ͻ 0.001), and exchanger protein abundance was significantly elevated in the hypertrophy ϩ ramipril group (*P Ͻ 0.05). These data are consistent with that shown in the hypertrophied groups for exchanger transcript abundance; however, the data are inconsistent with the functional data shown: exchanger protein is most abundant in the hypertrophy ϩ vehicle group, whereas maximal Ca 2ϩ extrusion was seen in the hypertrophy ϩ ramipril-treated group. Changes in exchanger mRNA and protein are therefore insufficient to explain the functional results obtained in the presence of caffeine.
DISCUSSION
Myocyte function as measured with RCCs.
The proteins responsible for relaxation in the rat are primarily the SR Ca 2ϩ -ATPase and secondarily the Na ϩ /Ca 2ϩ exchanger (2, 23, 26, 42) . The relative contribution of these proteins to relaxation varies according to the pathophysiological state (16, 30, 37) . Rapid cooling of cardiac cells to ϩ1°C in Ͻ1 s induces Ca 2ϩ release from the SR resulting in contracture (4, 8, 21) . Under such conditions, cytosolic Ca 2ϩ extrusion systems are inhibited. After rewarming these systems are reactivated; Ca 2ϩ is removed from the cytoplasm, and the cell relaxes. Bers and Bridge (3) used this method to inhibit different relaxation systems selectively. Relaxation after RCCs thus can be used to differentiate between individual components of relaxation. As with relaxation after a twitch, relaxation of hypertrophied cells after rapid cooling in normal Tyrode solution is significantly slower; however, unlike the twitch data, the slowed relaxation is accompanied by a slowing in the decline of intracellular Ca 2ϩ . This result can be explained by the much larger complete release of SR Ca 2ϩ produced by cooling, revealing compromised uptake and extrusion processes, whereas smaller releases of Ca 2ϩ normally produced by Ca 2ϩ -induced Ca 2ϩ release can be adequately handled.
The speed of relaxation is a good index of the efficiency of Ca 2ϩ extrusion systems (3, 39) . The rate of temperature change and transfer to Na ϩ -free/Ca 2ϩ -free solution that would normally disable the forward Na ϩ /H ϩ exchange should be rapid enough to prevent cellular acidosis. Because a small acidosis or the presence of caffeine could alter myofilament Ca 2ϩ sensitivity, direct measurements of cytoplasmic Ca 2ϩ changes using indo 1 fluorescence are preferable to measurements of cell length. This approach is not perfect, however, because alterations to myofilament sensitivity will induce alterations in Ca 2ϩ buffering and might lead to changes in the way Ca 2ϩ is handled. This is particularly true when studying a rodent model where changes in myofilament sensitivity are known to occur after cardiac hypertrophy. Data for both cell length and fluorescence have therefore been included in the analyses.
The results obtained in Na ϩ -free/Ca 2ϩ -free solution indicate that the hypertrophied myocytes are significantly slower to relax than controls and suggest that SR Ca 2ϩ uptake function is reduced in these myocytes.
After ramipril treatment, SR Ca 2ϩ uptake improved dramatically even without regression of myocyte hypertrophy. These results are consistent with our previous findings with low-dose ramipril where total SR Ca 2ϩ -ATPase activity was increased in crude cardiac homogenates isolated from compensated and hypertrophied rat hearts (6) . Although many studies have shown that ACE inhibitors can improve relaxation (20, 41, 44) , this is the first to show that ramipril treatment of established cardiac hypertrophy improves not only SR Ca 2ϩ -ATPase abundance but also myocyte relaxation directly through improved SR Ca 2ϩ uptake. In the absence of a functional SR (i.e., when caffeine is present) the decline in Ca 2ϩ back to resting levels after rewarming was also enhanced by ramipril. This result contradicts our original hypothesis where we postulated that Ca 2ϩ extrusion across the sarcolemma would be diminished. These data strongly suggest that ramipril has promoted more effective Ca 2ϩ efflux by the exchanger because it is the main Ca 2ϩ regulatory mechanism functioning under such conditions. The sarcolemmal Ca 2ϩ pump and the mitochondria would have been expected to contribute only about 1% to the fluxes of Ca 2ϩ associated with the production and sub- Fig. 7 . A: example of an RNase protection assay to quantify Na ϩ /Ca 2ϩ exchanger and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA abundance. Top bands represent protected fragments of cardiac Na ϩ /Ca 2ϩ exchanger (NCX1), and bottom bands indicate protected fragment of GAPDH. Protected fragments for NCX1 and GAPDH were 625 and 316 bp, respectively. Samples were from the four experimental groups as indicated, and atrial and liver RNA preparations were used as controls. The minus sign indicates lanes that were loaded with full-length probes for either NCX1 or GAPDH; the plus sign indicates lanes that were loaded with full-length probes for NCX1 or GAPDH and treated with RNases. B: summed data showing relative changes in Na ϩ / Ca 2ϩ exchanger expression among the four groups; n ϭ 6-8 hearts from each group. *P Ͻ 0.05, control ϩ vehicle vs. hypertrophy ϩ vehicle; **P Ͻ 0.01, control ϩ vehicle vs. control ϩ ramipril; and *P Ͻ 0.05, control ϩ vehicle vs. hypertrophy ϩ ramipril. sequent relaxation of a twitch or RCC in rat (2) . It is unclear why Ca 2ϩ efflux was not significantly enhanced after cardiac hypertrophy ϩ vehicle, even though protein levels were increased by nearly threefold. In humans, increased Na ϩ /Ca 2ϩ exchanger abundance is associated with preserved diastolic function (15) . Several possibilities might explain these results in rats: 1) species differences, 2) the protein does not incorporate correctly into the sarcolemmal membrane, 3) its activity in the membrane is not always a direct function of its abundance, or 4) changes in myofilament sensitivity or ion availability affect its function. Although the first two possibilities are difficult to test, there is evidence for the latter, i.e., changes in intracellular ion concentrations affect exchanger function independently of abundance. (5, 24, 34) including the well-established switch from ␣-MHC containing V1 myosin to ␤-MHC containing V3 myosin. This switch increases the energy efficiency of the myofilaments (34) . Although MHC isoform abundance was not measured in this study, a probable switch of V1 to the slower V3 myosin isoform might play a role in the Ca 2ϩ -independent slowing of relaxation during a twitch. However, changes in myocyte relaxation alone have been demonstrated in the V3-containing guinea pig heart, suggesting that other mechanisms may be involved (28) . Altered myofilament sensitivity could be due to factors such as changes in intracellular ATP, P i , pH, or cAMP (28) . Regardless, reduced myofilament responsiveness and relaxation is improved after treatment with ACE inhibitors (17, 20) .
Differential regulation. In the hypertrophied rat myocardium, Na ϩ /Ca 2ϩ exchanger mRNA abundance increased consistent with results from other hypertrophy models (14, 19, 25, 26) . In our model, Na ϩ /Ca 2ϩ exchanger (NCX1) mRNA expression increased significantly relative to GAPDH not only in the hypertrophy ϩ vehicle group but also in the control ϩ ramipril and hypertrophy ϩ ramipril groups. Previously in this same model we demonstrated a relative increase in PLB and SERCA2 mRNA in the control ϩ ramipril and hypertrophy ϩ ramipril groups (6) . Neither atrial natriuretic factor nor calsequestrin mRNA abundance were altered significantly in any of the groups after ramipril treatment (6) suggesting that the effects on mRNA expression are gene/transcript specific. Admin- summed data showing relative changes in Na ϩ /Ca 2ϩ exchanger protein abundance among the four experimental groups; n ϭ 6-8 hearts. Equal protein loading was ensured by amido black staining and use of myosin heavy chain antibodies (as described in METHODS). *P Ͻ 0.05, control ϩ ramipril vs. hypertrophy ϩ ramipril; and ***P Ͻ 0.001, control ϩ vehicle vs. hypertrophy ϩ vehicle.
istration of ramipril to control groups thus selectively increases the mRNA of SERCA2, PLB, and NCX1. Although it is unclear what mechanisms (transcriptional or posttranscriptional) are responsible for these selective increases, the subsequent discordance between RNA and protein abundance strongly implicates a degree of post-transcriptional regulation.
Although SR Ca 2ϩ -ATPase and Na ϩ /Ca 2ϩ exchanger protein content are controlled posttranscriptionally after ramipril treatment, the signaling events responsible for them are unknown. SERCA2 mRNA and protein abundance in the heart are also regulated posttranscriptionally during the perinatal period (31). Before birth, SERCA2 transcripts undergo specific splicing events in the 3Ј untranslated regions, implicating transcript processing as a potential mechanism involved in altering the mRNA stability [(31) and unpublished results]. Na ϩ /Ca 2ϩ exchanger protein abundance but not RNA levels are maintained after birth due to an apparent increase in the half-life of this protein (19) . With ramipril treatment, SERCA2 mRNA abundance did not change with cardiac hypertrophy, but SR Ca 2ϩ -ATPase protein abundance decreased, and uptake into the SR was significantly slowed (6) . In this report we also found that changes in NCX1 RNA abundance were not necessarily paralleled by changes in exchanger protein abundance. Takeishi and colleagues (38) recently postulated that ACE inhibition attenuates protein kinase C translocation and subsequent SR Ca 2ϩ -ATPase downregulation, providing a cellular mechanism underlying this posttranscriptional control. These data support a role for ANG-activated signal-transduction events, possibly via protein kinase intermediaries, in the posttranscriptional regulation SR Ca 2ϩ -ATPase and Na ϩ /Ca 2ϩ exchanger gene expression, protein abundance, and protein function in the adult rodent myocardium.
In conclusion, the slowing of myocyte relaxation in the compensated and hypertrophied cardiac myocyte is reversible with ramipril treatment. The reversal involves modifications to SR and sarcolemmal calcium cycling proteins. Specifically, ramipril treatment of rats with established cardiac hypertrophy improves myocyte TTP contraction and normalizes myocyte relaxation and Ca 2ϩ handling through improved SR uptake by the SR Ca 2ϩ -ATPase. Modest improvements in Ca 2ϩ efflux across the sarcolemmal membrane could be demonstrated via the Na ϩ /Ca 2ϩ exchanger but independent of direct changes in exchanger mRNA and/or protein expression. These results underscore the wideranging effects of ramipril treatment on calcium cycling proteins involving posttranscriptional control of protein abundance (SR Ca 2ϩ -ATPase and Na ϩ /Ca 2ϩ exchanger) and cellular mechanisms (ion concentrations) directly affecting protein function. Given the increased use of DNA arrays for analysis of expression profiles of normal and diseased myocardium, the finding of altered RNA abundances without concomitant changes in protein expression/function of multiple calcium cycling proteins after drug intervention is critical to future interpretations of genomic data derived from diseased hearts.
